Literature DB >> 24844453

Novel point mutations in survival motor neuron 1 gene expand the spectrum of phenotypes observed in spinal muscular atrophy patients.

Maria Jędrzejowska1, Monika Gos2, Janusz G Zimowski3, Anna Kostera-Pruszczyk4, Barbara Ryniewicz4, Irena Hausmanowa-Petrusewicz5.   

Abstract

The aim of our study was to identify point mutations in a group of 606 patients diagnosed for spinal muscular atrophy with excluded biallelic loss of the SMN1 gene. Point missense mutations or small deletions in the SMN1 gene were ultimately identified in 18 patients. Six patients were found to have small deletions, the c.429_435del mutation in 3 cases, the c.431delC mutation in 2 and c.722delC in one. Those mutations, not described previously, were characteristic of patients presenting a severe phenotype. The most frequent missense mutation - p.Thr274Ile, was identified in 9 patients presenting a rather mild phenotype. Three other missense mutations, i.e., p.Ser230Leu, p.Ala111Gly and p.Pro244Leu, were identified in a further 3 SMA3 patients. Mutation p.Pro244Leu, not described so far, was identified in a patient with a mild form of SMA and more distal distribution of muscle weakness. Our results suggest a specific point mutation spectrum in the Polish population. The existence of small deletions not identified thus far could suggest a possible founder effect. In patients with preserved one SMN1 allele without common exon 7 deletion, presenting a mild form of SMA, a special consideration should be given to the p.Thr274Ile mutation.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Point mutation; SMA; SMN1; SMN2; Spinal muscular atrophy

Mesh:

Substances:

Year:  2014        PMID: 24844453     DOI: 10.1016/j.nmd.2014.04.003

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  9 in total

1.  c.835-5T>G Variant in SMN1 Gene Causes Transcript Exclusion of Exon 7 and Spinal Muscular Atrophy.

Authors:  Shuang Wu; Yun-Lu Li; Ning-Yi Cheng; Chong Wang; En-Lin Dong; Ying-Qian Lu; Jin-Jing Li; Xin-Xin Guo; Xiang Lin; Lu-Lu Lai; Zhi-Wei Liu; Ning Wang; Wan-Jin Chen
Journal:  J Mol Neurosci       Date:  2018-05-24       Impact factor: 3.444

2.  Identification of processing elements and interactors implicate SMN, coilin and the pseudogene-encoded coilp1 in telomerase and box C/D scaRNP biogenesis.

Authors:  Aaron R Poole; Isioma I Enwerem; Ian A Vicino; Jackson B Coole; Stanley V Smith; Michael D Hebert
Journal:  RNA Biol       Date:  2016-07-15       Impact factor: 4.652

3.  Mild SMN missense alleles are only functional in the presence of SMN2 in mammals.

Authors:  Chitra C Iyer; Kaitlyn M Corlett; Aurélie Massoni-Laporte; Sandra I Duque; Narasimhan Madabusi; Sarah Tisdale; Vicki L McGovern; Thanh T Le; Phillip G Zaworski; W David Arnold; Livio Pellizzoni; Arthur H M Burghes
Journal:  Hum Mol Genet       Date:  2018-10-01       Impact factor: 6.150

Review 4.  Spinal muscular atrophy.

Authors:  Eugenio Mercuri; Charlotte J Sumner; Francesco Muntoni; Basil T Darras; Richard S Finkel
Journal:  Nat Rev Dis Primers       Date:  2022-08-04       Impact factor: 65.038

5.  Intragenic variants in the SMN1 gene determine the clinical phenotype in 5q spinal muscular atrophy.

Authors:  Rodrigo de Holanda Mendonça; Ciro Matsui; Graziela Jorge Polido; André Macedo Serafim Silva; Leslie Kulikowski; Alexandre Torchio Dias; Evelin Aline Zanardo; Davi Jorge Fontoura Solla; Juliana Gurgel-Giannetti; Ana Carolina Monteiro Lessa de Moura; Gabriela Palhares Campolina Sampaio; Acary Souza Bulle Oliveira; Paulo Victor Sgobbi de Souza; Wladimir Bocca Vieira de Rezende Pinto; Eduardo Augusto Gonçalves; Igor Braga Farias; Flávia Nardes; Alexandra Prufer de Queiroz Campos Araújo; Wilson Marques; Pedro José Tomaselli; Mara Dell Ospedale Ribeiro; João Paulo Kitajima; Fabíola Paoli Monteiro; Jonas Alex Morales Saute; Michele Michelin Becker; Maria Luiza Saraiva-Pereira; Ana Carolina Brusius-Facchin; Vanessa van der Linden; Rodrigo Neves Florêncio; André Vinícius Soares Barbosa; Marcela Camara Machado-Costa; André Luiz Santos Pessoa; Leticia Silva Souza; Marcondes Cavalcante Franca; Fernando Kok; Umbertina Conti Reed; Edmar Zanoteli
Journal:  Neurol Genet       Date:  2020-09-01

6.  Intragenic complementation of amino and carboxy terminal SMN missense mutations can rescue Smn null mice.

Authors:  Vicki L McGovern; Kaitlyn M Kray; W David Arnold; Sandra I Duque; Chitra C Iyer; Aurélie Massoni-Laporte; Eileen Workman; Aalapi Patel; Daniel J Battle; Arthur H M Burghes
Journal:  Hum Mol Genet       Date:  2020-11-01       Impact factor: 6.150

Review 7.  Advances in Newborn Screening and Presymptomatic Diagnosis of Spinal Muscular Atrophy.

Authors:  Maria Jędrzejowska
Journal:  Degener Neurol Neuromuscul Dis       Date:  2020-12-15

8.  Observation of the natural course of type 3 spinal muscular atrophy: data from the polish registry of spinal muscular atrophy.

Authors:  Anna Lusakowska; Maria Jedrzejowska; Anna Kaminska; Katarzyna Janiszewska; Przemysław Grochowski; Janusz Zimowski; Janusz Sierdzinski; Anna Kostera-Pruszczyk
Journal:  Orphanet J Rare Dis       Date:  2021-03-24       Impact factor: 4.123

9.  Analysis of FUS, PFN2, TDP-43, and PLS3 as potential disease severity modifiers in spinal muscular atrophy.

Authors:  Renske I Wadman; Marc D Jansen; Chantall A D Curial; Ewout J N Groen; Marloes Stam; Camiel A Wijngaarde; Jelena Medic; Peter Sodaar; Kristel R van Eijk; Manon M H Huibers; Joyce van Kuik; Henny H Lemmink; Wouter van Rheenen; Jan Herman Veldink; Leonard H van den Berg; W Ludo van der Pol
Journal:  Neurol Genet       Date:  2019-01-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.